Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.415 HKD | 0.00% | -2.35% | -9.78% |
03-26 | Mabpharm Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-10 | Livzon Pharma Recognizes Credit, Asset Impairments | MT |
Sales 2022 | 55.92M 7.72M 60.41M 10.55M | Sales 2023 | 87.16M 12.03M 94.17M 16.44M | Capitalization | 1.72B 238M 1.86B 325M |
---|---|---|---|---|---|
Net income 2022 | -211M -29.12M -228M -39.81M | Net income 2023 | -209M -28.84M -226M -39.43M | EV / Sales 2022 | 30.5 x |
Net Debt 2022 | 123M 16.94M 133M 23.15M | Net Debt 2023 | 109M 15.07M 118M 20.61M | EV / Sales 2023 | 21 x |
P/E ratio 2022 |
-7.52
x | P/E ratio 2023 |
-8.24
x | Employees | 347 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 22.82% |
1 week | -2.35% | ||
Current month | -16.16% | ||
1 month | -17.00% | ||
3 months | +20.29% | ||
6 months | -8.79% | ||
Current year | -9.78% |
Managers | Title | Age | Since |
---|---|---|---|
Hao Wang
CEO | Chief Executive Officer | 55 | 18-07-19 |
Yun Feng Li
DFI | Director of Finance/CFO | 47 | 18-07-19 |
Tao Jing
BRD | Director/Board Member | 51 | 18-08-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shu Ge Jiao
CHM | Chairman | 58 | 18-07-19 |
Ho Ming Leung
BRD | Director/Board Member | 41 | 22-06-16 |
Wei Zhu Qian
FOU | Founder | 48 | 15-02-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.415 | 0.00% | 0 |
24-04-25 | 0.415 | -7.78% | 50,000 |
24-04-24 | 0.45 | +5.88% | 2,000 |
24-04-23 | 0.425 | 0.00% | 0 |
24-04-22 | 0.425 | 0.00% | 62,000 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 04:08 am
More quotes1st Jan change | Capi. | |
---|---|---|
-9.78% | 219M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 2181 Stock